ProjectGAPVAC – Glioma Actively Personalized Vaccine Consortium / CIMT partner
Basic data
Acronym:
GAPVAC
Title:
Glioma Actively Personalized Vaccine Consortium / CIMT partner
Duration:
01/11/2012 to 01/11/2016
Abstract / short description:
The Glioma Actively Personalized VAccine Consortium (GAPVAC) is the first EU-funded initiative aimed at clinically developing biomarker-guided actively personalized vaccines (APVACs) to treat cancer patients.
Keywords:
Glioblastoma
immunotherapy
Immuntherapie
Peptide vaccine
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Immunology
Interfaculty Institute for Cell Biology (IFIZ), Interfaculty Institutes
Interfaculty Institute for Cell Biology (IFIZ), Interfaculty Institutes
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Local organizational units
Immunology
Interfaculty Institute for Cell Biology (IFIZ)
Interfaculty Institutes
Interfaculty Institutes
Funders
Brüssel, Belgium